Extended-spectrum β-lactamases, carbapenemases, 16S rRNA methylases conferring pan-drug aminoglycoside resistance and colistin resistance were investigated among Gram-negative bacteria recovered from clinical samples (infections) from 200 individuals hospitalized at the Khyber Teaching Hospital of Peshawar, north Pakistan, from December 2017 to March 2018. Out of 65 isolates recovered, 19%
Introduction
The increasing occurrence of resistance to carbapenems is a major issue for global public health. Resistance to carbapenems is often mediated by carbapenemases, with NDM-1 (New Delhi metallo-β-lactamase) being one of the most commonly identified carbapenemases worldwide, its main reservoir corresponding to the Indian subcontinent [1] . Accordingly, several studies reported a high occurrence of NDM-1 producers in India and Pakistan [2, 3] . Most of the carbapenemase producers are co-resistant to other antibiotic families, so it is interesting to obtain further characterization about those co-resistance markers [4] . Our aim was to characterize the carbapenemases, extended-spectrum β-lactamases (ESBLs), 16S rRNA methylases conferring pan-aminoglycoside resistance, and colistin resistance (plasmid-mediated mcr genes) from a series of clinical isolates obtained in acute-care facilities from Peshawar, Pakistan.
Materials and methods
Bacterial isolates A total of 200 samples were collected from 200 individuals between December 2017 and March 2018 at the Khyber Teaching Hospital of Peshawar, north Pakistan. Those samples included urine, blood, pus and broncheal lavage specimens. Samples were plated on URIselect-4™ medium (Bio-Rad, Cressier, Switzerland) and identification was performed using the API-20E system (bioMérieux, La Balme-les-Grottes, France). Antimicrobial susceptibility testing was performed using the disc diffusion method and interpreted according to the CLSI recommendations [5] , except for colistin. Resistance to colistin was evaluated first by using the Rapid Polymyxin test [6] , and then by determination of MIC values of colistin by broth microdilution, as recommended by European Committee on Antimicrobial Susceptibility Testing (EUCAST) (www. eucast.org). Carbapenemase and ESBL activities were detected using the Carba NP test [7] and the ESBL NP test [8] , respectively.
Molecular analysis
A series of acquired resistance genes were searched by PCR, including those encoding ESBLs (bla TEM -, bla SHV -and bla CTX-Mlike genes), carbapenemases (bla KPC , bla NDM , bla VIM , bla IMP , bla OXA-48 , bla OXA-181 ), 16S rRNA methylases genes (armA, rmtA to rmtH and npmA), and mcr-like genes (mcr-1 to mcr-8) [9] [10] [11] [12] [13] [14] . The obtained amplicons were sent for sequencing (Micro-synth®, Balgach, Switzerland).
Clonal diversity
Clonal relationship of the isolates was evaluated by pulsed-field gel electrophoresis (PFGE) [15] . Total DNA from Escherichia coli, Klebsiella pneumoniae and Enterobacter spp. were digested using the XbaI enzyme (New England Biolabs, Ipswich, MA, USA). The generated fragments were separated by PFGE using a CHEF-DR III System (Bio-Rad) creating a unique PFGE profile for each clonal strain. Multilocus sequencing typing was performed for pan-drug aminoglycoside-resistant strains belonging to the species E. coli (strain no. 31) and K. pneumoniae (strain no. 62) [16] . Sequence types (STs) were investigated using the online databases (http://genomicepidemiology.org/).
Results
A total of 65 Gram-negative bacteria were recovered including 46 E. coli, 10 Enterobacter spp. (9 Enterobacter cloacae, 1 Enterobacter sakazakii), 6 K. pneumoniae, 2 Alcaligenes faecalis and 1 Citrobacter freundii.
Thirty-eight of the 65 Gram-negative bacteria produced a carbapenemase, as assessed by the results of the Rapid Carba NP test, whereas 32 of those 65 isolates produced an ESBL according to the results of the ESBL NP test. Among the 46 E. coli isolates, 12 produced NDM-1, 5 co-produced NDM-1 and CTX-M-15, 2 co-produced NDM-1 and OXA-181, 2 isolates co-producing OXA-181 and CTX-M-15, a single isolate producing OXA-48. Twelve E. coli isolates produced CTX-M-15 without any carbapenemase associated. A single bla NDM-1 -positive E. coli isolate produced the 16S rRNA methylase RmtB.
Among the six K. pneumoniae isolates, one isolate coproduced NDM-1 and CTX-M-15, another co-produced NDM-1, OXA-181 and CTX-M-15, and a single isolate co-produced NDM-1, OXA-232 and CTX-M-15 together with the 16S rRNA methylase RmtB (see Table 1 ).
The ten Enterobacter spp. isolates (nine Enterobacter cloacae, one Enterobacter sakazakii) co-produced NDM-1 and CTX-M-15.
Two Alcaligenes faecalis isolates were identified, both producing a carbapenemase VIM-4.
The single C. freundii isolate did not produce any carbapenemase but was positive for CTX-M-15. None of the isolates was resistant to colistin. PFGE analysis showed a very high clonal diversity for all those isolates producing a carbapenemase, except among Enterobacter spp. with a single clone being identified among six patients (EC-1) that may have resulted from an outbreak.
By using MLST, we showed that the bla NDM-1 and rmtBpositive E. coli clone belonged to ST215 (strain no. 31) and that the multidrug-resistant K. pneumoniae isolate belonged to ST231 (strain no. 62).
Discussion
Here we evaluated the occurrence of multidrug resistance from infecting strains ( [19] .
Interestingly, some strains were found to harbour two unrelated carbapenemase genes (bla NDM-1 and bla OXA-181 ), as observed previously in Singapore [20] , Nigeria [21] and Romania [22] .
In our study, co-resistance to multiple antibiotics was commonly observed among those carbapenem-resistant isolates, with 60% of them harbouring at least two other resistance genes (ESBL, or 16S rRNA methylase gene). A single K. pneumoniae isolate carried two carbapenemase genes, namely bla NDM-1 and bla OXA-232 , along with the ESBL-encoding gene bla CTX-M-15 and the 16S rRNA methylase gene rmtB. That isolate was an ST231 clone, already described in South-East Asia [23, 24] and Switzerland [25] , and associated with OXA-232.
Among the 16S rRNA methylase genes, the methylase gene rmtB, rather than rmtF, was mostly identified here, which is not surprising owing to the spread of rmtB-positive strains in Pakistan [26] . Our study showed the frequent identification of the ESBL CTX-M-15 among those multidrug-resistant bacteria. It is possible that the spread of CTX-M-15 that is observed worldwide originated from the Indian subcontinent because we identified the first CTX-15 producers from India in 2001 [27] . Our study confirms the frequent association of those three important resistance markers that are NDM, ESBL of the CTX- M-15 type and 16S rRNA methylases as a source of multidrug resistance. This combination complicates the treatment of infected patients. We also identified two A. faecalis isolates producing a same VIM-4 metallo-β-lactamase. Occurrence of carbapenemase production in that bacterial species is rare. Only a single case of A. faecalis carrying bla VIM-4 has been described in Gaza, Palestine [28] . Further work may identify the genetic basis of such acquisition of carbapenemase. Other reports about ESBL in clinical isolates of Alcaligenes species have been described in Malaysia [29] , France [30] and Italy [31] .
Finally, no resistance to colistin was observed whereas MCR-1-mediated colistin resistance isolates was observed recovered from E. coli in animals [32, 33] and from a single patient [34] in Pakistan. Lack of colistin resistance among those multidrugresistant isolates is good news as it would indicate the availability to use that drug for treating infected patients in this country.
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